The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 17 April 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 123K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, S. D.
Right arrow Articles by Chao, Y.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, S. D.
Right arrow Articles by Chao, Y.-S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2000/4/1437/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 8, April 17, 2000 1437-1442


Brief Definitive Report

Infectious Agents Are Not Necessary for Murine Atherogenesis

Samuel D. Wrighta, Charlotte Burtona, Melba Hernandeza, Heide Hassinga, Judy Montenegroa, Steve Mundta, Sushma Patela, Deborah J. Carda, Anne Hermanowski-Vosatkaa, James D. Bergstroma, Carl P. Sparrowa, Patricia A. Detmersa, and Yu-Sheng Chaoa

a Department of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Merck Research Laboratories, Lipid Biochemistry, P.O. Box 2000, RY80W-250, 126 E. Lincoln Ave., Rahway, NJ 07065.732-594-1169732-594-3086

samuel_wright{at}merck.com

Recent work has revealed correlations between bacterial or viral infections and atherosclerotic disease. One particular bacterium, Chlamydia pneumoniae, has been observed at high frequency in human atherosclerotic lesions, prompting the hypothesis that infectious agents may be necessary for the initiation or progression of atherosclerosis. To determine if responses to gram-negative bacteria are necessary for atherogenesis, we first bred atherosclerosis-prone apolipoprotein (apo) E–/– (deficient) mice with animals incapable of responding to bacterial lipopolysaccharide. Atherogenesis was unaffected in doubly deficient animals. We further tested the role of infectious agents by creating a colony of germ-free apo E–/– mice. These animals are free of all microbial agents (bacterial, viral, and fungal). Atherosclerosis in germ-free animals was not measurably different from that in animals raised with ambient levels of microbial challenge. These studies show that infection is not necessary for murine atherosclerosis and that, unlike peptic ulcer, Koch's postulates cannot be fulfilled for any infectious agent in atherosclerosis.

Key Words: atherosclerosis • apolipoprotein E knockout • germ-free animal • Toll • cholesterol


© 2000 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS